NextPlat Announces Completion of Merger and Business Combination with Progressive Care Inc. as Company Focuses on Growth in Healthcare, Technology and Personal Wellness Markets
NextPlat Corp (NASDAQ: NXPL) has completed the merger and business combination with Progressive Care Inc., making Progressive Care a wholly-owned subsidiary of NextPlat. As a result, Progressive Care's common stock has ceased trading on the OTCQB exchange effective October 1, 2024.
Under the terms of the merger, Progressive Care shareholders received 1.4865 newly issued shares of NextPlat common stock for each share of Progressive Care common stock they owned. The exchange was conducted automatically for shares held in brokerage and retirement accounts. Shareholders with physical stock certificates are requested to contact NextPlat's transfer agent, Equity Stock Transfer, for transfer instructions.
Charles M. Fernandez, Executive Chairman and CEO of NextPlat, stated that the merger creates a unified company focused on growth in healthcare services, technology, and personal health and wellness markets. He noted strong top-line growth and improving operational performance in the first half of 2024 and expects continued improvements in consolidated financial performance through business integration and new product launches.
NextPlat Corp (NASDAQ: NXPL) ha completato la fusione e la combinazione aziendale con Progressive Care Inc., rendendo Progressive Care una filiale interamente controllata di NextPlat. Di conseguenza, le azioni ordinarie di Progressive Care hanno cessato di essere negoziate sul mercato OTCQB a partire dal 1 ottobre 2024.
Secondo i termini della fusione, gli azionisti di Progressive Care hanno ricevuto 1.4865 nuove azioni ordinarie di NextPlat per ogni azione comune di Progressive Care posseduta. Lo scambio è avvenuto automaticamente per le azioni detenute in conti di intermediazione e pensionistici. Gli azionisti con certificati azionari fisici sono invitati a contattare l'agente di trasferimento di NextPlat, Equity Stock Transfer, per le istruzioni sul trasferimento.
Charles M. Fernandez, Presidente Esecutivo e CEO di NextPlat, ha dichiarato che la fusione crea un azienda unificata focalizzata sulla crescita nei servizi sanitari, nella tecnologia e nei mercati della salute e del benessere personale. Ha notato una forte crescita del fatturato e un miglioramento delle performance operative nella prima metà del 2024, e si aspetta ulteriori miglioramenti nelle performance finanziarie consolidate attraverso l'integrazione aziendale e i nuovi lanci di prodotto.
NextPlat Corp (NASDAQ: NXPL) ha completado la fusión y combinación empresarial con Progressive Care Inc., convirtiendo a Progressive Care en una subsidiaria de propiedad total de NextPlat. Como resultado, las acciones comunes de Progressive Care han dejado de cotizar en el mercado OTCQB a partir del 1 de octubre de 2024.
Bajo los términos de la fusión, los accionistas de Progressive Care recibieron 1.4865 nuevas acciones comunes de NextPlat por cada acción común de Progressive Care que poseían. El intercambio se realizó automáticamente para las acciones mantenidas en cuentas de corretaje y de jubilación. Se solicita a los accionistas con certificados de acciones físicos que se comuniquen con el agente de transferencia de NextPlat, Equity Stock Transfer, para recibir instrucciones sobre la transferencia.
Charles M. Fernandez, Presidente Ejecutivo y CEO de NextPlat, declaró que la fusión crea una empresa unificada enfocada en el crecimiento en servicios de salud, tecnología y mercados de salud y bienestar personal. Observó un fuerte crecimiento de los ingresos y una mejora en el rendimiento operativo en la primera mitad de 2024 y espera continuas mejoras en el rendimiento financiero consolidado a través de la integración empresarial y los lanzamientos de nuevos productos.
NextPlat Corp (NASDAQ: NXPL)는 Progressive Care Inc.와의 합병 및 사업 결합을 완료했습니다. 이를 통해 Progressive Care는 NextPlat의 전속 자회사가 되었습니다. 그 결과, Progressive Care의 보통주는 2024년 10월 1일부터 OTCQB 거래소에서 거래가 중단되었습니다.
합병 조건에 따라, Progressive Care의 주주들은 보유한 Progressive Care의 보통주 1주당 1.4865주새로운 NextPlat 보통주를 받았습니다. 이 거래는 중개 및 퇴직 계좌에 보유된 주식에 대해 자동으로 수행되었습니다. 주식 증서가 있는 주주들은 NextPlat의 이전 대리인인 Equity Stock Transfer에 연락하여 이전 지침을 요청해야 합니다.
NextPlat의 실행 회장 겸 CEO인 Charles M. Fernandez는 합병이 의료 서비스, 기술 및 개인 건강 및 웰빙 시장에서의 성장에 집중하는 통합 회사를 창출한다고 밝혔습니다. 그는 2024년 상반기에 강력한 매출 성장과 운영 성과 개선을 보았으며, 사업 통합 및 신제품 출시를 통해 지속적인 통합 재무 성과 개선을 기대하고 있습니다.
NextPlat Corp (NASDAQ: NXPL) a achevé la fusion et la combinaison d'entreprise avec Progressive Care Inc., faisant de Progressive Care une filiale entièrement détenue par NextPlat. En conséquence, les actions ordinaires de Progressive Care ont cessé d'être négociées sur le marché OTCQB à compter du 1er octobre 2024.
Selon les termes de la fusion, les actionnaires de Progressive Care ont reçu 1,4865 nouvelles actions ordinaires de NextPlat pour chaque action ordinaire de Progressive Care qu'ils possédaient. L'échange a été effectué automatiquement pour les actions détenues dans des comptes de courtage et de retraite. Les actionnaires possédant des certificats d'actions physiques sont invités à contacter l'agent de transfert de NextPlat, Equity Stock Transfer, pour des instructions de transfert.
Charles M. Fernandez, président exécutif et PDG de NextPlat, a déclaré que la fusion crée une entreprise unifiée axée sur la croissance dans les services de santé, la technologie et les marchés de la santé et du bien-être personnel. Il a noté une forte croissance du chiffre d'affaires et une amélioration de la performance opérationnelle au cours de la première moitié de 2024 et s'attend à de nouvelles améliorations des performances financières consolidées grâce à l'intégration des entreprises et au lancement de nouveaux produits.
NextPlat Corp (NASDAQ: NXPL) hat die Fusion und Geschäftskombination mit Progressive Care Inc. abgeschlossen, wodurch Progressive Care zu einer hundertprozentigen Tochtergesellschaft von NextPlat geworden ist. Infolgedessen hat der Handel mit den Stammaktien von Progressive Care am OTCQB-Markt eingestellt, gültig ab dem 1. Oktober 2024.
Gemäß den Bedingungen der Fusion erhielten die Aktionäre von Progressive Care 1,4865 neu ausgegebene Stammaktien von NextPlat für jede von ihnen gehaltene Stammaktie von Progressive Care. Der Austausch wurde automatisch für in Broker- und Rentenkonten gehaltene Aktien durchgeführt. Aktionäre mit physischen Aktienzertifikaten werden gebeten, den Übertragungsbeauftragten von NextPlat, Equity Stock Transfer, für Übertragungsanweisungen zu kontaktieren.
Charles M. Fernandez, Executive Chairman und CEO von NextPlat, erklärte, dass die Fusion ein einheitliches Unternehmen schafft, das sich auf Wachstum in den Bereichen Gesundheitsdienstleistungen, Technologie und persönliche Gesundheit- und Wellnessmärkte konzentriert. Er wies auf ein starkes Umsatzwachstum und eine Verbesserung der Betriebsleistung in der ersten Hälfte von 2024 hin und erwartet weiterhin Verbesserungen der konsolidierten finanziellen Leistung durch Unternehmensintegration und Produktneuheiten.
- Merger completed, creating a unified company focused on growth in healthcare, technology, and wellness markets
- Strong top-line growth and improving operational performance reported for the first half of 2024
- Expected improvements in consolidated financial performance through business integration and new product launches
- Progressive Care's common stock ceased trading on the OTCQB exchange
- Potential integration challenges and redundancies elimination may affect short-term operations
Insights
The merger between NextPlat and Progressive Care marks a significant strategic move, potentially reshaping NextPlat's market position. This consolidation aims to leverage synergies in healthcare services, technology and wellness markets, which could drive revenue growth and operational efficiencies.
Key points to consider:
- The 1.4865 share exchange ratio for Progressive Care shareholders indicates NextPlat's confidence in the acquired assets.
- The delisting of Progressive Care from OTCQB suggests a streamlined corporate structure, potentially improving investor visibility and liquidity through NextPlat's NASDAQ listing.
- Management's emphasis on "strong top-line growth" and "improving operational performance" in H1 2024 is promising, but investors should look for concrete financial metrics in upcoming reports.
- The focus on eliminating redundancies and business integration could lead to cost savings, potentially improving margins.
- New product launches planned for the coming year may drive additional revenue streams, but their success remains to be seen.
While the merger presents growth opportunities, investors should monitor integration progress and financial performance in the coming quarters to assess the deal's true value.
This merger positions NextPlat to capitalize on the rapidly evolving healthcare and wellness markets. The integration of Progressive Care's expertise in pharmacy services with NextPlat's e-commerce capabilities could create a unique value proposition in the healthcare technology space.
Key considerations for investors:
- The combined entity may be better equipped to address the growing demand for telehealth and digital health solutions, potentially capturing a larger market share.
- Progressive Care's pharmacy network could provide a strong foundation for NextPlat to expand its healthcare services offerings.
- The merger may enable the development of innovative health tech products, leveraging NextPlat's technology background and Progressive Care's healthcare insights.
- The focus on personal health and wellness aligns with current consumer trends, potentially opening up new revenue streams in the direct-to-consumer market.
However, investors should be aware that integrating healthcare operations with a technology-focused company can be complex and regulatory compliance in the healthcare sector will be crucial. The success of this merger will largely depend on effective integration and the ability to innovate while navigating the highly regulated healthcare landscape.
Progressive Care Stock to Cease Trading Today, October 1, 2024
"The completion of our merger and business combination with Progressive Care creates a unified company focused on generating continued growth in large domestic and global markets for healthcare services, technology and personal health and wellness. Through the first half of 2024, each of our business operations have successfully generated strong top-line growth and steadily improving operational performance, and through elimination of redundancies, business integration and the launch of new products planned throughout next year, we expect to produce continued improvements in our consolidated financial performance," said Charles M. Fernandez, Executive Chairman and CEO of NextPlat Corp.
Under terms of the Merger Agreement, Progressive Care shareholders received 1.4865 newly issued shares of NextPlat common stock for each share of Progressive Care common stock they own immediately prior to the effective time of the Business Combination. The exchange of shares was conducted automatically for shares of Progressive Care common stock held in brokerage and retirement accounts. All Progressive Care shareholders who hold physical stock certificates are requested to promptly contact NextPlat's transfer agent, Equity Stock Transfer, for transfer and delivery instructions. Equity Stock Transfer can be reached at 237 W 37th St, Suite 601,
About NextPlat Corp
NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the Company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in
About Progressive Care
Progressive Care Inc., through its subsidiaries, is a
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce capabilities for consumer and healthcare products and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net
View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplat-announces-completion-of-merger-and-business-combination-with-progressive-care-inc-as-company-focuses-on-growth-in-healthcare-technology-and-personal-wellness-markets-302263927.html
SOURCE NextPlat Corp.
FAQ
What is the exchange ratio for Progressive Care shareholders in the NextPlat (NXPL) merger?
When did Progressive Care's stock cease trading following the merger with NextPlat (NXPL)?
What markets will the merged NextPlat (NXPL) and Progressive Care company focus on?